PDF(Pubmed)
Abstract：
Cardiogenic shock continues to carry a high mortality rate despite contemporary care, with no breakthrough therapies shown to improve survival over the past few decades. It is a time-sensitive condition that commonly results in cardiovascular complications and multisystem organ failure, necessitating multidisciplinary expertise. Managing patients with cardiogenic shock remains challenging even in well-resourced settings, and an important subgroup of patients may require cardiac replacement therapy. As a result, the idea of leveraging the collective cognitive and procedural proficiencies of multiple providers in a collaborative, team-based approach to care (the \"shock team\") has been advocated by professional societies and implemented at select high-volume clinical centers. A slowly maturing evidence base has suggested that cardiogenic shock teams may improve patient outcomes. Although several registries exist that are beginning to inform care, particularly around therapeutic strategies of pharmacologic and mechanical circulatory support, none of these are currently focused on the shock team approach, multispecialty partnership, education, or process improvement. We propose the creation of a Cardiogenic Shock Team Collaborative-akin to the successful Pulmonary Embolism Response Team Consortium-with a goal to promote sharing of care protocols, education of stakeholders, and discovery of how process and performance may influence patient outcomes, quality, resource consumption, and costs of care.
摘要：
尽管有当代护理，心源性休克仍然具有很高的死亡率，在过去的几十年中，没有突破性的疗法可以改善生存率。这是一种时间敏感的疾病，通常会导致心血管并发症和多系统器官衰竭，需要多学科的专业知识。即使在资源充足的环境中，管理心源性休克患者仍然具有挑战性，一个重要的亚组患者可能需要心脏替代治疗。因此,在协作中利用多个提供者的集体认知和程序能力的想法，以团队为基础的护理方法("休克小组")一直受到专业协会的倡导,并在部分高容量临床中心实施.逐渐成熟的证据基础表明，心源性休克团队可能会改善患者的预后。虽然有几个登记册开始通知护理，特别是围绕药物和机械循环支持的治疗策略，这些都不是目前专注于冲击团队的方法，多专业伙伴关系，教育,或过程改进。我们建议创建一个类似于成功的肺栓塞反应团队联盟的心源性休克团队协作-目标是促进护理方案的共享。利益相关者的教育，以及过程和表现如何影响患者结果的发现，质量,资源消耗,和护理费用。
